Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Bionetide for the Treatment of Girls and Women With Rett Syndrome
NCT06840496 is registered in ClinicalTrials.gov with Biomed Industries, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Bionetide for the Treatment of Girls and Women With Rett Syndrome
- Lead sponsor
- Biomed Industries, Inc.
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- September 30, 2026
- Completion date
- December 30, 2027
- Enrollment
- 210 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.